Clinical and preclinical studies have linked synapse loss and impaired prefrontal cortex (PFC) function to behavioral and cognitive symptoms of psychiatric diseases, such as major depressive disorder (MDD). Preclinical models, such as chronic unpredictable stress (CUS), are important tools to study these pathophysiological mechanisms as they recapitulate key neurobiological (i.e., synapse loss in PFC) and behavioral (i.e., anhedonia, working memory impairment) aspects of MDD. This is significant because exposure to psychosocial or environmental stressors increases risk of development and recurrence of psychiatric disease. Accumulating evidence shows that the brain-resident macrophages, microglia, have an active role in regulating neuroplasticity in physiological and pathological conditions. In support of this work, research in our lab indicates that dynamic neuron-microglia interactions contribute to neurobiological and behavioral consequences following chronic stress. In particular, CUS increases neuronal colony stimulating factor-1 (CSF1) signaling in the medial PFC, which provokes microglia-mediated neuronal remodeling that contributes to synaptic deficits and behavioral and cognitive consequences. Stress-induced release of glucocorticoids are implicated in the pathophysiology of psychiatric diseases. The actions of glucocorticoids are mediated by glucocorticoid receptors (GR), which regulate gene transcription. Indeed prior work shows that GR signaling alters gene networks that drive structural remodeling and synapse loss on pyramidal neurons in the PFC. Our recent studies indicate that GR signaling induces neuronal CSF1 signaling in the PFC and provokes microglia-mediated neuronal remodeling in the PFC, which contributes to development of depressive behaviors after CUS. This work also revealed that GR signaling regulates specific molecular pathways in neurons (REDD1; regulated in development and DNA damage response 1) and microglia (TNF?; tumor necrosis factor-?). These findings are relevant because both neuronal REDD1 and microglial TNF? have critical roles in regulating synaptic plasticity. Studies in this application will determine the contributions of neuronal or microglial GR signaling and respective downstream mediators in the pathophysiology underlying behavioral consequences of chronic stress. Here we will use brain region- and cell type-specific genetic and pharmacological manipulations to test two specific aims: 1) Define the role of neuronal GR signaling and downstream REDD1 in stress-induced CSF1 signaling, microglia-mediated neuronal remodeling, and associated behavioral consequences; and 2) Examine the role of microglial GR signaling and downstream TNF? in stress- induced microglia-mediated neuronal remodeling, synaptic deficits, and associated behavioral consequences. These studies are significant because they will identify molecular and cellular adaptations that initiate stress- induced synapse loss in the PFC. We expect to generate novel insight into cell type-specific pathways that drive the neurobiology of stress, which may guide treatment strategies for psychiatric disease.
Behavioral and cognitive symptoms of many psychiatric diseases are linked to synaptic loss in the prefrontal cortex. Converging evidence indicates that dynamic neuron-microglia interactions contribute to synaptic deficits in the prefrontal cortex following chronic stress. This application will examine the role of neuron- and microglia- specific molecular mechanisms that initiate synapse loss and resultant behavioral and cognitive impairments.
